Gene · 8321
NIH grants1,683
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,683
Download this page as JSON| Grant | Title | FZD1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA160069 | Hepatic Stellate Cell Regulation of Metastatic Growth in the Liver | 1 | 2025 |
| R01CA164719 | Anti-cancer vaccine targeting the host-parasite interface during fluke infection | 1 | 2025 |
| R01CA250082 | Therapeutic targeting Wnt5A signaling for advanced prostate cancer | 1 | 2025 |
| R01CA251253 | Modulating HSP70/STUB1 machinery in therapy-resistant prostate cancer | 1 | 2025 |
| R01CA251374 | Inhibiting tumor growth and metastasis in highly aggressive breast cancers with centrosome amplification | 1 | 2025 |
| R01CA260239 | Proteolysis-targeting chimera against BCL-XL inhibits breast cancer metastasis | 1 | 2025 |
| R01CA260351 | Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer | 1 | 2025 |
| R01CA262536 | Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs | 1 | 2025 |
| R01CA266704 | Enhancing the Efficacy of Docetaxel in Prostate Cancer | 1 | 2025 |
| R01CA271452 | Regulation of prostate epithelial basal cell plasticity | 1 | 2025 |
| R01CA271457 | Stromal Foxf2 suppresses prostate cancer progression | 1 | 2025 |
| R01CA276217 | Ablating Liver Metastases with SBRT to Enhance Immune Checkpoint Blockade in Melanoma | 1 | 2025 |
| R01DA012864 | Mechanisms and Cellular Function of Opioid Receptor Endocytosis | 1 | 2025 |
| R01DC004336 | Engineering the Vocal Fold Mucosa | 1 | 2025 |
| R01DE011111 | P. gingivalis interactions with gingival epithelial cells | 1 | 2025 |
| R01DK062027 | Mechanisms of Adrenal Differentiation | 1 | 2025 |
| R01DK062277 | Role of Wnt-Beta-catenin in liver development and metabolic zonation | 1 | 2025 |
| R01DK085691 | Colon O-glycosylated mucus in the homeostasis of microbiota and host | 1 | 2025 |
| R01DK099097 | Functional outcomes of inflammatory bowel disease associated variants | 1 | 2025 |
| R01ES027778 | Mechanism for arsenic induced carcinogenesis | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8321/grants?page=8